In autistic spectrum disorder (ASD) there are dysregulated synapses.
There is now more knowledge on emerging mechanisms and mechanism-based therapies.
Insulin-like growth factor (IGF-1) is altered in autism.
IGF-1 may rescue function in Rett syndrome and in SCHANK3 gene deficiency syndrome.
There are now pilot studies of treatment of ASD.